CAN/598
WTO/TBT
CA Canada
  • 11 - Health care technology
  • 30 - Pharmaceutical products
2019-11-01
2019-09-02

Prescription status of medicinal ingredients for human use (ICS: 11.120; HS 3004.90)

Notice of Consultation on the Prescription Drug List (PDL): Epinephrine (2 pages, in English and French)

This Notice of Consultation provides an opportunity to comment on the proposal to add epinephrine or its salts topical solution for hemostasis when sold at a concentration equal to or greater than 1 mg/ ml (1:1000) to the Prescription Drug List (PDL).  Only the Human part of the PDL is proposed to be revised.